4 completed, 3 terminated. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 3, Completed 2 |
| Phase 1 | 2 | Completed 2 |
Follow irosustat: new trials by email Literature Review of irosustat trials Research Report on irosustat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer. Irosustat - Locally Advanced Breast Cancer, Metastatic Breast Cancer | Phase 2 | Completed | Imperial College London | 27 | 2012-10-01 | 2015-03-24 |
| A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth Irosustat - Breast Neoplasms | Phase 2 | Terminated | Imperial College London | 13 | 2012-08-01 | 2016-03-14 |
| Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer BN83495 - Breast Cancer | Phase 2 | Terminated | Ipsen | 2 | 2011-05-01 | 2019-01-07 |
| Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy BN83495 - Endometrial Cancer | Phase 2 | Terminated | Ipsen | 6 | 2010-11-01 | 2019-01-14 |
| The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer BN83495, Megestrol Acetate (MA) - Endometrial Cancer | Phase 2 | Completed | Ipsen | 73 | 2009-08-01 | 2019-01-30 |
| BN83495 in Prostate Cancer BN83495 (Cohort 1), BN83495 (Cohort 2), BN83495 (Cohort 3) - Prostate Cancer | Phase 1 | Completed | Ipsen | 17 | 2009-01-01 | 2019-01-15 |
| BN83495 Phase I in Post-menopausal Women Irosustat (BN83495) - Breast Cancer | Phase 1 | Completed | Ipsen | 50 | 2007-04-01 | 2019-11-22 |
Breast Neoplasms (4) · Endometrial Neoplasms (2) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1)
Ipsen (5) · Imperial College London (2)
United Kingdom (4) · Belgium (2) · France (2) · United States (2) · Canada (1) · Czechia (1) · Hungary (1) · Latvia (1) · Lithuania (1) · Moldova (1) · Norway (1) · Poland (1) · Russia (1) · Spain (1) · Ukraine (1)
Carlo Palmieri (1) · Carlo Palmieri, BSc MBBS PhD (1)
2009 (1)